MARAVAI LIFESCIENCES HLDGS-A (MRVI) Stock Income Statement
NASDAQ:MRVI - Nasdaq - US56600D1072 - Common Stock - Currency: USD
| TTM (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 241.86M | 259.19M | 288.94M | 883.00M | 799.20M | |||
| Minority Interest Expense | 127.08M | 114.78M | 19.35M | -270.50M | -287.20M | |||
| Cost Of Goods | 151.67M | 150.88M | 148.74M | 169.00M | 140.60M | |||
| Gross Profit | 90.19M | 108.31M | 140.20M | 714.00M | 658.70M | |||
| Operating Expenses | 177.52M | 178.99M | 165.38M | 139.80M | 115.20M | |||
| Research and Development | 19.08M | 19.22M | 14.68M | 15.60M | 9.30M | |||
| Selling, General, and Administrative Expenses | 159.85M | 159.17M | 151.39M | 129.30M | 100.10M | |||
| Operating Income | -87.33M | -70.68M | -25.18M | 574.20M | 543.40M | |||
| Interest Income/Expense | -20.20M | -20.30M | -18.16M | -18.10M | -30.30M | |||
| Other Income/Expense | -2.46M | -2.38M | 667.55M | -4.50M | 6.40M | |||
| Non Recurring Items | -181.77M | -168.12M | -6.47M | -200.00K | 11.20M | |||
| Income Before Taxes | -291.76M | -261.48M | 617.74M | 551.50M | 530.80M | |||
| Income Tax | -1.97M | -1.86M | 756.11M | 60.80M | 61.50M | |||
| Net Income | -162.71M | -144.85M | -119.03M | 220.20M | 182.00M | |||
| EBITDA | -27.21M | -13.81M | 23.60M | 606.10M | 568.10M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -1.15 | -1.05 | -0.90 | 0.86 | 0.70 | |||
| Non GAAP EPS | -0.16 | -0.10 | 0.03 | 1.80 | 1.59 | |||
| Statistics | ||||||||
| Gross Profit Margin | 37.29% | 41.79% | 48.52% | 80.86% | 82.42% | |||
| Profit Margin | -67.28% | -55.89% | -41.19% | 24.94% | 22.77% | |||
| Operating Profit Margin | -36.11% | -27.27% | -8.72% | 65.03% | 67.99% | |||
All data in USD